Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2025-12-30 @ 8:08 AM
Study NCT ID:
NCT00954135
Status:
UNKNOWN
Last Update Posted:
2009-08-07
First Post:
2009-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients
Sponsor:
University of Turin, Italy
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09
Start Date Type:
None
Primary Completion Date:
2010-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2010-12
Completion Date Type:
ESTIMATED
First Submit Date:
2009-08-06
First Submit QC Date:
None
Study First Post Date:
2009-08-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-08-06
Last Update Post Date:
2009-08-07
Last Update Post Date Type:
ESTIMATED